CD34 Monoclonal Antibody [QBEND-10] - Unconjugated / 0.1ml IQ77 from ImmuQuest Ltd. | Biocompare.com

Supplier Images

CD34 Antibody [QBEND-10]

CD34 Antibody [QBEND-10]

Be the first to write a review!

Citations:

Supplier Page from
ImmuQuest Ltd. for
CD34 Monoclonal Antibody [QBEND-10] - Unconjugated / 0.1ml

ImmuQuest Ltd.'s CD34 Monoclonal Antibody [QBEND-10] - Unconjugated / 0.1ml is a Mouse monoclonal antibody. The CD34 Monoclonal Antibody [QBEND-10] - Unconjugated / 0.1ml was generated using CD34 as the antigen. It reacts with Human, and Non-Human Primate. This antibody has been shown to work in applications such as: Precipitation, Flow Cytometry, Immunohistochemistry, Immunohistochemistry - fixed, Immunohistochemistry - frozen, Immunoprecipitation, and Western Blot.

Product Specs
ItemCD34 Monoclonal Antibody [QBEND-10] - Unconjugated / 0.1ml
CompanyImmuQuest Ltd.
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberIQ77
ApplicationsFlow Cyt, IHC-Fr, IP, IHC-P, WB
ReactivityHuman, Cynomolgus Monkey, Rhesus monkey
ImmunogenHuman endothelial vesicles
HostMouse
PurityProtein A affinity chromatography
FormatPurified tissue culture supernatant in phosphate buffered saline containing 0.02% sodium azide
Quantity0.1mg
IsotypeIgG1
Concentration1mg/ml
NCBI Full Gene NameCD34 molecule
CloneQBEND-10
ClonalityMonoclonal
Conjugate/TagUnconjugated
TargetCD34

Specifications/Features

Myeloma/fusion partners: NSO myeloma cell line

Add to Compare List

ImmuQuest Ltd.

ImmuQuest Ltd.

Springboard Business Centre

Ellerbeck Way Stokesley Business Park

N.Yorkshire TS9 5JZ

United Kingdom

Company Profile

Website: http://www.immuquest.com

(1) Exosomal microRNA-144 from bone marrow-derived mesenchymal stem cells inhibits the progression of non-small cell lung cancer by targeting CCNE1 and CCNE2Stem cell research & therapyFebruary 26, 2020Liang Y, Zhang D, Li L, Xin T, Zhao Y, Ma R, Du J.

(2) Volumetric imaging: a potential tool to stage upper tract urothelial carcinomaWorld journal of urologyNovember 1, 2019Grahn A, Tanaka N, Uhlén P, Brehmer M.

(3) Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2AgingAugust 5, 2019Yu L, Gui S, Liu Y, Qiu X, Zhang G, Zhang X, Pan J, Fan J, Qi S, Qiu B.

(4) Poor outcome in hypoxic endometrial carcinoma is related to vascular densityBritish journal of cancerMay 1, 2019Reijnen C, van Weelden WJ, Arts MSJP, Peters JP, Rijken PF, van de Vijver K, Santacana M, Bronsert P, Bulten J, Hirschfeld M, et al.

(5) Enhanced wound healing promotion by immune response-free monkey autologous iPSCs and exosomes vs. their allogeneic counterpartsEBioMedicineApril 1, 2019Lu M, Peng L, Ming X, Wang X, Cui A, Li Y, Wang X, Meng D, Sun N, Xiang M, et al.

(6) Morphological characteristics of vasculogenic mimicry and its correlation with EphA2 expression in gastric adenocarcinomaScientific reportsMarch 4, 2019Kim HS, Won YJ, Shim JH, Kim HJ, Kim J, Hong HN, Kim BS.

(7) Long noncoding RNA NEXN-AS1 mitigates atherosclerosis by regulating the actin-binding protein NEXNThe Journal of clinical investigationMarch 1, 2019Hu YW, Guo FX, Xu YJ, Li P, Lu ZF, McVey DG, Zheng L, Wang Q, Ye JH, Kang CM, et al.

(8) Differential expression of p120-catenin 1 and 3 isoforms in epithelial tissuesScientific reportsJanuary 14, 2019Venhuizen JH, Sommer S, Span PN, Friedl P, Zegers MM.

(9) Inhibition of Triple-Negative Breast Cancer Tumor Growth by Electroacupuncture with Encircled Needling and Its Mechanisms in a Mice Xenograft ModelInternational journal of medical sciencesJanuary 1, 2019Jiang X, Tian Y, Xu L, Zhang Q, Wan Y, Qi X, Li B, Guo J, Sun W, Luo A, et al.

(10) Prevalence and clinicopathological characteristics of lipomatous neurofibromas in neurofibromatosis 1: An investigation of 229 cutaneous neurofibromas and a systematic review of the literatureJournal of cutaneous pathologyOctober 1, 2018Rozza-de-Menezes RE, Brum CAI, Gaglionone NC, de Sousa Almeida LM, Andrade-Losso RM, Paiva BVB, Faveret PLS, da Silva AV, Siqueira OHK, Riccardi VM, et al.

(11) Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arraysOncotargetApril 6, 2018Barbhuiya MA, Kashyap MK, Puttamallesh VN, Kumar RV, Wu X, Pandey A, Gowda H.

(12) HMG-CoA Reductase Inhibitors Relieve Endoplasmic Reticulum Stress by Autophagy Inhibition in Rats With Permanent Brain IschemiaFrontiers in neuroscienceJanuary 1, 2018Zhang T, Lu D, Yang W, Shi C, Zang J, Shen L, Mai H, Xu A.

(13) Stent-Jailing Technique Reduces Aneurysm Recurrence More Than Stent-Jack Technique by Causing Less Mechanical Forces and Angiogenesis and Inhibiting TGF-β/Smad2,3,4 Signaling Pathway in Intracranial Aneurysm PatientsFrontiers in physiologyJanuary 1, 2018Xu N, Meng H, Liu T, Feng Y, Qi Y, Zhang D, Wang H.

(14) Corneal keratocyte transition to mesenchymal stem cell phenotype and reversal using serum-free medium supplemented with fibroblast growth factor-2, transforming growth factor-β3 and retinoic acidJournal of tissue engineering and regenerative medicineJanuary 1, 2018Sidney LE, Hopkinson A.

(15) High expression of angiogenic factor AGGF1 is an independent prognostic factor for hepatocellular carcinomaOncotargetDecember 19, 2017Tu J, Ying X, Zhang D, Weng Q, Mao W, Chen L, Wu X, Tu C, Ji J, Huang Y.

(16) Expression of ING4 is negatively correlated with cellular proliferation and microvessel density in human gliomaOncology lettersSeptember 1, 2017Shao B, Liu E.

(17) Case report of ocular Kaposi's sarcomaBMC ophthalmologyAugust 14, 2017Yang J, Yin XF, Li YP, Zhou SY.

(18) Pediatric and adult dilated cardiomyopathy represent distinct pathological entitiesJCI insightJuly 20, 2017Patel MD, Mohan J, Schneider C, Bajpai G, Purevjav E, Canter CE, Towbin J, Bredemeyer A, Lavine KJ.

(19) Effects of cryopreservation on excretory function, cellular adhesion molecules and vessel lumen formation in human umbilical vein endothelial cellsMolecular medicine reportsJuly 1, 2017Cai G, Lai B, Hong H, Lin P, Chen W, Zhu Z, Chen H.

(20) Targeting Wnt/β-Catenin Activated Cells with Dominant-Negative N-cadherin to Reduce Neointima FormationMolecular therapy. Methods & clinical developmentJune 16, 2017Hulin-Curtis S, Williams H, Wadey KS, Sala-Newby GB, George SJ.

Be the First to Write a Review!